Privium Fund Management B.V.
Privium Fund Management B.V. reported 61 US-listed holdings worth $544.2 million in its 13F for the quarter ended 30 June 2026, filed 7 August 2026. Its largest: Tesla, Inc. (17.6%), Shopify Inc. (7.8%) and Advanced Micro Devices Inc. (6.6%). Against the quarter before, it opened 12 positions, added to 18, trimmed 18 and sold out of 11.
Reported holdings$544.2M+13.3% on Q1 2026
Positions61+1 on Q1 2026
The largest ten61.8%of its reported holdings
Latest 13FQ2 2026filed 7 August 2026
OpenedAdded toHeldTrimmed
The 14 largest of its 61 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned +75.4% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Its reported holdingsThe S&P 500
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Opened 12Added 18Held 13Trimmed 18Sold out 11
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 12
- Opendoor Technologies Inc. OPEN$18.2 million
- Cerebras Systems Inc. Com Class A CBRS$13.4 million
- Space Exploration Techn Corp. Class A Com STK SPCX$6.8 million
- Magnum Ice Cream Co. NV MICC$1.5 million
- Zoetis Inc. ZTS$1.2 million
- Legend Biotech Corp. LEGN$1.0 million
- TotalEnergies SE TTE$729,486
- Nu Holdings Ltd. NU$587,840
and 4 more in the table below
Added to 18
- Amazon.com Inc. AMZN+15,000 shares · +12%
- Tesla, Inc. TSLA+6,000 shares · +3%
- Ionis Pharmaceuticals Inc. IONS+29,900 shares · +10%
- Arcutis Biotherapeutics Inc. ARQT+78,395 shares · +24%
- Sarepta Therapeutics, Inc. SRPT+90,500 shares · +197%
- Hims & Hers Health, Inc. HIMS+40,000 shares · +100%
- Biogen Inc. BIIB+4,600 shares · +11%
- Lemonade Inc. LMND+15,000 shares · +6%
and 10 more in the table below
Trimmed 18
- Arrowhead Pharmaceuticals, Inc. ARWR-132,714 shares · -36%
- Uniqure NV QURE-158,198 shares · -33%
- Spotify Technology S.A. SPOT-12,000 shares · -18%
- Axsome Therapeutics Inc. AXSM-18,785 shares · -32%
- Shopify Inc. SHOP-37,000 shares · -9%
- Molina Healthcare, Inc. MOH-5,161 shares · -63%
- 4D Molecular Therapeutics in FDMT-80,146 shares · -47%
- Urogen Pharma Ltd URGN-28,122 shares · -12%
and 10 more in the table below
Sold out of 11
- Coinbase Global, Inc. COIN$13.8 million last quarter
- Sea Limited SE$11.4 million last quarter
- Esperion Therapeutics Inc. Ne ESPR$9.0 million last quarter
- Engene Holdings Inc. ENGN$2.4 million last quarter
- Stoke Therapeutics Inc. STOK$1.6 million last quarter
- Pfizer Inc. PFE$1.5 million last quarter
- SLB Limited SLB$948,197 last quarter
- Seabridge Gold Inc. SA$703,626 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Tesla, Inc. TSLA | 228.0K | $95.9 million | 17.62% | +6.0K |
| Shopify Inc. SHOP | 370.0K | $42.2 million | 7.76% | -37.0K |
| Advanced Micro Devices Inc. AMD | 62.0K | $36.0 million | 6.62% | no change |
| Amazon.com Inc. AMZN | 140.0K | $33.4 million | 6.13% | +15.0K |
| Ionis Pharmaceuticals Inc. IONS | 319.9K | $25.4 million | 4.66% | +29.9K |
| Spotify Technology S.A. SPOT | 55.0K | $25.3 million | 4.64% | -12.0K |
| Palantir Technologies Inc. PLTR | 200.0K | $23.3 million | 4.29% | no change |
| Arrowhead Pharmaceuticals, Inc. ARWR | 234.2K | $19.1 million | 3.51% | -132.7K |
| Opendoor Technologies Inc. OPEN | 3.9M | $18.2 million | 3.35% | new |
| Lemonade Inc. LMND | 270.3K | $17.6 million | 3.23% | +15.0K |
| NVIDIA Corp. NVDA | 81.0K | $16.2 million | 2.98% | no change |
| Iris Energy Ltd IREN | 340.1K | $15.6 million | 2.86% | +20.0K |
| Uniqure NV QURE | 328.3K | $15.1 million | 2.78% | -158.2K |
| Cerebras Systems Inc. Com Class A CBRS | 60.5K | $13.4 million | 2.46% | new |
| Ast Spacemobile Inc. ASTS | 145.0K | $12.9 million | 2.37% | no change |
| Ultragenyx Pharmaceutical in RARE | 338.8K | $11.3 million | 2.08% | -26.0K |
| Arcutis Biotherapeutics Inc. ARQT | 399.4K | $10.5 million | 1.92% | +78.4K |
| Biogen Inc. BIIB | 48.4K | $10.5 million | 1.92% | +4.6K |
| Proqr Thrapeutics N V PRQR | 5.5M | $10.3 million | 1.89% | +52.9K |
| Axsome Therapeutics Inc. AXSM | 39.9K | $9.8 million | 1.80% | -18.8K |
| Urogen Pharma Ltd URGN | 210.0K | $7.7 million | 1.42% | -28.1K |
| Space Exploration Techn Corp. Class A Com STK SPCX | 40.0K | $6.8 million | 1.26% | new |
| Denali Therapeutics Inc. DNLI | 229.9K | $5.9 million | 1.09% | -25.0K |
| Vertex Pharmaceuticals Inc. VRTX | 9.4K | $4.7 million | 0.86% | -2.0K |
| Biomarin Pharmaceutical Inc. BMRN | 75.0K | $4.3 million | 0.79% | -17.3K |
| Krystal Biotech, Inc. KRYS | 11.2K | $4.2 million | 0.76% | no change |
| Alnylam Pharmaceuticals Inc ALNY | 11.4K | $3.4 million | 0.63% | -850 |
| Viridian Therapeutics Inc. VRDN | 173.5K | $3.2 million | 0.59% | no change |
| BioNTech SE BNTX | 30.1K | $2.8 million | 0.51% | +3.1K |
| Hims & Hers Health, Inc. HIMS | 80.0K | $2.8 million | 0.51% | +40.0K |
| Meiragtx Holdings PLC MGTX | 196.1K | $2.6 million | 0.49% | -16.0K |
| Ambev S.A. ABEV | 802.2K | $2.5 million | 0.46% | -146.4K |
| Sarepta Therapeutics, Inc. SRPT | 136.5K | $2.5 million | 0.45% | +90.5K |
| Crispr Therapeutics AG CRSP | 45.0K | $2.5 million | 0.45% | +2.1K |
| Beam Therapeutics Inc. BEAM | 70.3K | $2.4 million | 0.44% | +6.3K |
| Zai Lab Limited ZLAB | 122.2K | $2.3 million | 0.43% | -10.0K |
| Moderna, Inc. MRNA | 30.0K | $2.1 million | 0.39% | no change |
| Selecta Biosciences, Inc. RNAC | 151.7K | $1.6 million | 0.29% | -27.4K |
| Magnum Ice Cream Co. NV MICC | 98.2K | $1.5 million | 0.27% | new |
| Wave Life Sciences Ltd WVE | 241.0K | $1.4 million | 0.26% | no change |
| Taysha Gene Therapies Inc. TSHA | 198.9K | $1.4 million | 0.25% | +17.0K |
| Zoetis Inc. ZTS | 17.3K | $1.2 million | 0.23% | new |
| 4D Molecular Therapeutics in FDMT | 90.1K | $1.2 million | 0.22% | -80.1K |
| Fate Therapeutics Inc. FATE | 414.3K | $1.1 million | 0.21% | no change |
| Legend Biotech Corp. LEGN | 35.4K | $1.0 million | 0.19% | new |
| Rocket Pharmaceuticals Inc. RCKT | 244.1K | $834,979 | 0.15% | +2.0K |
| NOV Inc. NOV | 42.0K | $779,582 | 0.14% | no change |
| B2GOLD Corp. BTG | 195.1K | $729,610 | 0.13% | +98.6K |
| TotalEnergies SE TTE | 10.7K | $729,486 | 0.13% | new |
| Lexeo Therapeutics Inc. LXEO | 155.0K | $722,300 | 0.13% | -50.0K |
| Transocean Ltd RIG | 145.6K | $712,004 | 0.13% | +39.0K |
| Molina Healthcare, Inc. MOH | 3.0K | $681,297 | 0.13% | -5.2K |
| Nu Holdings Ltd. NU | 44.0K | $587,840 | 0.11% | new |
| Autolus Therapeutics PLC AUTL | 363.4K | $581,488 | 0.11% | no change |
| Tidewater Inc. TDW | 8.7K | $578,548 | 0.11% | +3.2K |
| lululemon athletica Inc. LULU | 5.1K | $578,093 | 0.11% | new |
| Sandridge Energy Inc. SD | 38.8K | $531,450 | 0.10% | no change |
| Seabridge Gold Inc. Com SA | 16.5K | $425,019 | 0.08% | new |
| Voyager Therapeutics Inc. VYGR | 120.0K | $420,000 | 0.08% | no change |
| Engene Therapeut ENGN | 170.0K | $294,100 | 0.05% | new |
| Cosan S A CSAN | 52.0K | $149,760 | 0.03% | new |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.